Search
Search Results
-
Effect of exercise before and/or during taxane-containing chemotherapy treatment on chemotherapy-induced peripheral neuropathy symptoms in women with breast cancer: systematic review and meta-analysis
PurposeTo systematically review and meta-analyse the efficacy of exercise interventions delivered before and/or during taxane-containing chemotherapy...
-
Chemotherapy-induced thrombocytopenia: literature review
Chemotherapy-induced thrombocytopenia (CIT) is a common condition that frequently results in reduced chemotherapy dosages, postponed treatment,...
-
Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer
BackgroundBreast cancer chemotherapy utilization not only may differ by race and age, but also varies by genomic risk, tumor characteristics, and...
-
Retrospective evaluation of Penguin Cold Caps for chemotherapy-induced alopecia
BackgroundScalp cooling is an increasingly recognized non-pharmacologic approach to minimize chemotherapy-induced alopecia (CIA). Several...
-
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
Malignancies of the peritoneal cavity are associated with a dismal prognosis. Systemic chemotherapy is the gold standard for patients with...
-
Increased EAT volume after anthracycline chemotherapy is associated with a low risk of cardiotoxicity in breast cancer
PurposeChemotherapy-induced cardiotoxicity is a critical issue for patients with breast cancer. Change of epicardial adipose tissue (EAT) is...
-
Effect of duration of adjuvant chemotherapy with S-1 (6 versus 12 months) for resected pancreatic cancer: the multicenter clinical randomized phase II postoperative adjuvant chemotherapy S-1 (PACS-1) trial
BackgroundSix-month adjuvant chemotherapy with S-1 is standard care for resected pancreatic cancer in Japan; however, the optimal duration has not...
-
Real-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based Chemotherapy
IntroductionDocetaxel is an established standard therapy after osimertinib and platinum-based doublet chemotherapy (Pt-doublet) for locally advanced...
-
Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens
BackgroundEpidermal growth factor receptor-tyrosine kinase inhibitors (EGFR TKIs) are established first-line treatments among patients with...
-
Can AI-based body composition assessment outperform body surface area in predicting dose-limiting toxicities for colonic cancer patients on chemotherapy?
PurposeGold standard chemotherapy dosage is based on body surface area (BSA); however many patients experience dose-limiting toxicities (DLT). We...
-
Body composition and chemotherapy toxicities in breast cancer: a systematic review of the literature
PurposeBreast cancer is the most diagnosed cancer in women with chemotherapy being a common treatment. Toxicities due to chemotherapy can result in...
-
Initiating chemotherapy in joint arthroplasty patients increases the risk of periprosthetic joint infections
BackgroundTotal Joint Arthroplasties (TJAs) are becoming more popular, resulting in a growing economic burden due to potential postoperative...
-
Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study
BackgroundSurgical resection of oligo-metastasis in gastric cancer (GC) is weakly recommended for patients without other incurable factors in the...
-
Metronomic Chemotherapy in Elderly Patients
Purpose of ReviewThis review describes the most relevant studies found in the scientific literature regarding metronomic chemotherapy (MCT) in the...
-
Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy
The standard of treatment for node-positive endometrial cancer (FIGO Stage IIIC) in North America has been systemic therapy with or without...
-
Pediatric adrenocortical carcinoma: clinical features and application of neoadjuvant chemotherapy
ObjectiveTo summarize the clinical characteristics of children with adrenocortical carcinoma (ACC) and preliminarily explore the indications for and...
-
Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer
BackgroundThe DYNAMIC trial investigated the use of circulating tumor DNA (ctDNA) to guide adjuvant treatment decisions in stage II colon cancer....
-
Right ventricle involvement in patients with breast cancer treated with chemotherapy
BackgroundAnthracyclines can cause left ventricular (LV) dysfunction. There is little data about right ventricular (RV) damage during chemotherapy.
...
-
Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer
IntroductionCurrent guidelines recommendations regarding chemotherapy in small (T1b and T1c), node-negative triple-negative breast cancer (TNBC)...
-
Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study
PurposeSystemic chemotherapy (SYS) is the first-line treatment of unresectable intrahepatic cholangiocarcinoma (ICC). However, the survival benefit...
